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Report of in vitro antileishmanial properties of Iberian macroalgae 30 
Abstract 31 
Here is reported the anti Leishmania infantum activity of 45 hexane, dichloromethane and 32 
ethanol extracts from 16 macroalgae collected on the Iberian Coast. Seven hexane and 33 
dichloromethane Cystoseira baccata, C.barbata, C. tamariscifolia, C. usneoides, Dictyota 34 
spiralis and Plocamium cartilagineum extracts were active towards promastigotes (IC50 29.8-35 
101.8 µg/mL) inducing strong morphological alterations in the parasites. Hexane extracts of 36 
C. baccata and C. barbata were also active against intracellular amastigotes (IC50 5.1 and 6.8 37 
µg/mL, respectively). Fatty acids, triacylglycerols, carotenoids, steroids, and meroterpenoids 38 
were detected by nuclear magnetic resonance (NMR), and gas chromatography (GC) in the 39 
Cystoseira extracts. These results suggest that Cystoseira macroalgae contain compounds 40 
with antileishmanial activity, which could be explored as scaffolds to the development of 41 
novel sources of antiparasitic derivatives. 42 
Keywords: Antiparasitic, Leishmania infantum; Leishmaniasis; Macroalgae; Cystoseira; 43 
Secondary metabolites. 44 
1. Introduction  45 
Leishmaniases are vector-borne diseases caused by Leishmania parasites, and transmitted by 46 
phlebotomine sand flies, which affect more than 12 million people in 98 countries (Alvar et 47 
al. 2012). Drugs available for controlling leishmaniases have serious side effects and limited 48 
effectiveness due to growing parasite resistance. In this context, the development of novel 49 
drugs is of paramount importance (Sundar & Chakravarty 2015). Marine resources are 50 
recognized as rich sources of compounds for the biodiscovery of novel drug leads which 51 
could also be used for antileishmanial therapy and control (Tempone et al.2011). Several 52 
macroalgae species show to be toxic to Leishmania parasites however few publications 53 
described the identification of promising molecules for future studies regarding leishmaniases 54 
treatment (Yamthe et al., 2017). This study evaluated the in vitro activity of hexane (HEX), 55 
dichloromethane (DCM) and methanolic (MeOH) extracts of 16 macroalgae species from the 56 
Iberian coast against L. infantum, the species responsible for the canine leishmaniasis and the 57 
most severe form of human disease, thevisceral leishmaniasis. Results suggested that 58 
Cystoseira contain compounds with antileishmanial activity. 59 
 
2. Results and discussion  60 
Screening of 16 macroalgae extracts using the MTT colorimetric assay enabled the detection 61 
of activity against L. infantum promastigotes in six species (Tables S1 and S2). Most of the 62 
identified bioactive extracts that decreased promastigote viability by 50% at concentrations 63 
lower than 94 µg/mL belonged to Cystoseira species, effects similar to those obtained for 64 
crude extracts of other algae of the same phylum (Yamthe et al., 2017). Altough axenic 65 
promastigotes are often used for the in vitro preliminary drug screening, promising products 66 
should be evaluated on the clinical relevant stage in the vertebrate host, the intracellular 67 
amastigotes (Tempone et al. 2011). C. tamariscifolia and C. usneoides HEX and DCM 68 
extracts were the most active (IC50 29.8 - 33.6 µg/mL) against promastigote forms. However, 69 
its high toxicity against THP-1 mammalian cells prevented its evaluation upon the 70 
intracellular model (Figure 1). Conversely, C. baccata and C. barbata HEX extracts that 71 
decreased by half the promastigote viability at 94.1 and 78.7 µg/mL presented good 72 
selectivity when assayed against the intracellular model. Incubation with the aforementioned 73 
extracts decreased infection by 50% at 5.1 and 6.8 µg/mL, respectively, with cytotoxicity 74 
similar to that of the reference drug miltefosine (Figure 1; Table S2). These results showed 75 
that the C. baccata and C. barbata HEX extracts displayed higher leishmanicidal activity than 76 
those described for other Cystoseira against axenic (IC50 > 23.5 µg/mL; Süzgeç-Selçuk et al. 77 
2010) and intracellular (IC50 > 15.7 µg/mL; Spavieri et al. 2010) L. donovani amastigotes.  78 
The effect of Cystoseira extracts on promastigotes was also analysed by optical microscopy, 79 
revealing the occurrence of morphological changes (Figure S1) similar to those observed after 80 
treatment of Leishmania promastigotes with extracts from marine sponges (Kahla-Nakbi et 81 
al., 2010). Extracts induced motility loss, cell shrinkage, abnormal round cell shapes, 82 
vacuolated and slightly denser cytoplasm as well as reduction of flagellar length in parasite 83 
cells (Figure S1D). Loss of motility and cellular vacuolization could be consequence of 84 
starvation processes caused by a deficient mitochondrial activity, autophagic mechanisms or 85 
cytoplasmic organelle disruption (Lockshin & Zakeri 2004; Monte Neto et al., 2011). These 86 
results together with the absence of phosphatidylserine externalization, observed in 87 
promastigotes treated with the extracts for 48h (data not shown), suggest that crucial 88 
organelles, such as mitochondria, are compromised and that the observed leishmanicidal 89 
effect might not be associated with programmed cell death. 90 
Chemical profiles of the active Cystoseira extracts investigated using different analytical 91 
methods (NMR, GC/FID and GC/LREIMS) reveal the occurrence of different classes of 92 
 
metabolites (Table S3; Figures S2 and S3)in agreement with previous studies focusing on 93 
Cystoseira (Bruno de Sousa, et al. 2017a). Unsaturated fatty acids such as arachidonic and 94 
eicosapentaenoic (EPA) acids were found in the HEX extracts. EPA was found to be effective 95 
against L. donovani promastigotes (Vassallo et al. 2011) and triacylglycerols against L. 96 
aethiopica (Bekele et al. 2013) and L. amazonensis (Rodrigues et al. 2014). Steroids such as 97 
cholesterol, sitosterol, stigmasterol and fucosterol, also identified in all the analysed HEX 98 
extracts. The antileishmanial effect of fucosterol and sitosterol isolated from other biological 99 
sources has already been reported (Bruno de Sousa et al., 2017b). Concerning 100 
meroterpenoids, E- and Z-usnoidones were identified in the Cystoseira studied extracts. Other 101 
meroterpenoids were also detected in bioactive CH2Cl2 extracts, except from C. 102 
tamariscifolia. Meroterpenoids have already been described as having several bioactive 103 
properties (Reyes et al. 2013) including antileishmanial (Bruno de Sousa et al. 2017a). 104 
Although their effect on Leishmania has been associated with the inhibition of adenosine 105 
phosphoribosyltransferase (Gray et al. 2006), their antileishmanial activity remains poorly 106 
studied.  107 
3. Conclusions 108 
Our results suggest that Cystoseira are a source of metabolites with activity against L. 109 
infantum. In that context, further bioguided fractionation of the active Cystoseira extracts 110 
should be carried out in order to identify the active components. 111 
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FIGURE CAPTIONS 155 
Figure 1. Effect of the L. infantum and mammalian cells treatment with Cystoseira spp. 156 
active hexane extracts and the reference drug Miltefosine. Significant differences between 157 
extracts and reference drug are indicated as *,p < 0.05; **, p < 0.01; ***, p < 0.001 (Student’s 158 
t-test). 159 
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Here  is  reported  the anti  Leishmania  infantum activity  of  45  hexane,  dichloromethane  and
ethanol  extracts  from  16  macroalgae  collected  on  the  Iberian  Coast.  Seven  hexane  and
dichloromethane  Cystoseira  baccata,  C.barbata,  C.  tamariscifolia,  C.  usneoides,  Dictyota
spiralis and  Plocamium cartilagineum extracts  were active towards promastigotes (IC50 29.8-
101.8 µg/mL) inducing strong morphological alterations in the parasites. Hexane extracts of C.
baccata  and  C.  barbata  were  also  active  against  intracellular  amastigotes  (IC50 5.1  and 6.8
µg/mL,  respectively).  Fatty  acids,  triacylglycerols,  carotenoids,  steroids,  and  meroterpenoids
were detected  by nuclear  magnetic  resonance  (NMR),  and gas  chromatography  (GC) in  the
Cystoseira extracts. These results suggest that  Cystoseira macroalgae contain compounds with
antileishmanial  activity,  which  could  be  explored  as  scaffolds  to  the  development  of  novel
sources of antiparasitic derivatives. 


















Samples  from  15  different  species  belonging  to  the  Rhodophyta,  Chlorophyta  and
Heterokontophyta phyla were collected between July, 2010 and July, 2013 at different locations
of the Portuguese and Spanish coasts (Table S1). Morphological identification was made by Dr
Aschwin  Engelen,  Dr  Tânia  Pereira  and  MSc Mafalda  Tavares  (CCMAR-UAlg),  Dr  Javier
Cremades  (Facultad  de  Ciencias,  University  of  A  Coruña,  Spain)  and  Dr  Ricardo  Bermejo
(University  of  Cadiz,  Spain).  Biomass  was  washed  with  water  to  remove  epiphytes,  before
freeze-drying, then grounded and stored at -20 °C until  use. Vouchers specimens are kept at
MarBiotech herbarium at the Centre of Marine Sciences, Faro, Portugal.
2. Extracts preparation
Dried  biomass  was  blended  with  hexane  (1:10  w/v)  by  means  of  an  IKA Ultra-Turrax
disperser for 1 min for cell  wall  disruption,  and after centrifugation (5000 ×  g,  10 min) the
supernatants  were recovered.  The extraction was repeated three times.  The residue was then
sequentially extracted with CH2Cl2 and MeOH in a similar manner. All extracts were evaporated
under reduced pressure at 40  ºC and stored at 4 °C. For the bioactivity assays, extracts were
dissolved in DMSO (dimethyl sulfoxide) at the concentration of 50 mg/mL.
3. Chemical characterization of Cystoseira extracts
3.1. NMR analysis
Hydrogen nuclear magnetic resonance (1H NMR) spectra were recorded on a Bruker Avance
III  500  spectrometer,  using  5  mm  TXI  probe,  operated  at  500.13  MHz  for  1H  nucleus.
Approximately 10 mg of each sample was dissolved in 0.6 mL of CDCl3 with tetramethylsilane
(TMS) as a standard reference with a chemical shift H = 0.00 ppm. Spectra were obtained at 25
C, with 64 scans, 2 dummy scans, using a 90-degree high power pulse of 8.3 µs, a recycle delay
of 1s, and 64 K data points covering a spectral width of 7684 Hz. All spectra were processed
using Topspin 3.2 software.































Gas  chromatography  with  flame  ionization  detector  (GC/FID)  chromatograms  were
recorded on a Shimadzu GC-2010 gas chromatograph equipped with an FID-detector and an
automatic  injector  (Shimadzu  AOC-20i)  using  a  RtX-5  capillary  column  (5% phenyl,  95%
polydimethylsiloxane, 30 m × 0.32 mm × 0.25 μm film thickness; Restek, USA). These analysesm film thickness; Restek, USA). These analyses
were performed by injecting 1.0 μm film thickness; Restek, USA). These analysesL of a 1.0 mg/mL solution of crude hexane extract in hexane in
a  split  mode  (1:30)  employing  helium  as  the  carrier  gas  (1  mL/min)  under  the  following
conditions:  injector  and  detector  temperatures  of  +270  ºC  and  300  ºC,  respectively;  oven
programmed  temperature  from  120–290  °C  at  8  °C/min,  holding  20  min  at  290  ºC.  Gas
chromatography–low resolution electron ionization mass spectrometry (GC/LREIMS) analysis
was conducted in a Shimadzu GC-17A chromatograph interfaced with a MS-QP-5050A mass
spectrometer operating using ionization voltage of 70 eV and an ion source temperature of +350
°C with the same conditions described above. Helium was used as the carrier gas. 
4. Antileishmanial and cytotoxicity assays
4.1. Cytotoxicity against human acute monocytic leukaemia cell line THP-1
Cytotoxicity of all extracts was performed on human acute monocytic leukaemia cell line
THP-1 (ATCC TIB-202). Cells were cultivated in RPMI-1640 medium supplemented with 10%
heat-inactivated  foetal  bovine  serum  (FBS),  L-glutamine  (2  mM),  penicillin  (50  U/L)  and
streptomycin (0.05 mg/L) at 37 ºC in humidified atmosphere with 5% CO2. For the assay, 105
THP-1 cells per well were seeded onto the 96-well plates. Extracts were added at concentrations
ranging from 4 to 125 µg/mL for 48h, and cell viability was determined by the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide)  colorimetric  assay,  as  described
elsewhere (Dutta et al., 2005). Cells used as negative control were treated with DMSO at the
highest  concentration  used in  test  wells  (0.5% v/v).  Results  were expressed in  terms of  cell
viability (%) and half maximal inhibitory concentration values (IC50 – in µg/mL).
4.2. Antipromastigote assay
Promastigote forms of a  L. infantum strain (MHOM/PT/88/IMT-151) were obtained from
the cryobank of the ‘Instituto de Higiene e Medicina Tropical’ (Universidade Nova de Lisboa,
Portugal) and maintained in RPMI-1640 medium supplemented with 10% FBS, L-glutamine,
































plates with the extracts at concentrations ranging from 4 to 125 μm film thickness; Restek, USA). These analysesg/mL for 48h. Negative control
cells  were  treated  with  DMSO  at  the  highest  concentration  used  in  test  wells  (≤1%  v/v).
Amphotericin B (0.2 µg/mL), miltefosine (12.7 µg/mL) and pentamidine (0.5 µg/mL) were used
as positive controls. The effect of the extracts on parasite viability was assessed by the MTT
colorimetric assay. Results were expressed in terms of cell viability (%) and IC50 values (µg/mL).
4.3. Activity against intracellular amastigotes
L. infantum intracellular amastigotes (MHOM/MA(BE)/67) were collected from the spleen
of heavily infected donor hamsters and used to infect primary peritoneal mouse macrophages
(PMM). PMM (3 × 104 cells per well) were seeded on 96-well plates, and incubated for two days
for cell attachment. Then, 5 × 105 amastigotes were added to each well (infection ratio about 16
amastigotes per cell)  and infected macrophages were further incubated at 37  ºC for 2 h. The
extracts  at  concentrations  ranging from 0.25 to 64.0 µg/mL were added and the plates were
further incubated at  37  ºC and 5% CO2.  After 5 days,  intracellular  amastigote burdens were
microscopically  assessed upon Giemsa staining and the inhibitory concentration conferring a
50%  reduction  of  the  intracellular  amastigote  burden  compared  to  the  non-treated  infected
positive controls (CC50) was determined. In addition, cytotoxicity of the extracts was evaluated
on PMM cells and carried out as previously described  (Cos et al., 2016). The reference drug
(miltefosine) was used as positive control.
.
4.4. Microscopic analysis
Leishmania promastigotes  were  incubated  with  the  extracts  (125  µg/mL)  and  with
amphotericin (0.2 µg/mL) for 48h. After incubation and centrifugation, parasites were smeared
on microscope slides, fixed with methanol and stained with Giemsa solution and observed using
a Zeiss AXIOMAGER Z2 microscope, equipped with a cool SNApHQ2 camera and AxioVision
software version 4.8 (Carl Zeiss MicroImaging GmbH, Göttingen, Germany). 
4.5. Apoptosis detection through annexin V-FITC staining
Promastigotes (4 x 106/mL) cultured in RPMI medium with DMSO (0.1%) were treated with
IC50 concentrations  of  with  Cystoseira  extracts  at  IC50 concentrations  for  48h.  Negative  and
































1% v/v) and amphotericin B (0.6 µg/mL), respectively. Apoptotic effect of the tested extracts on
L.  infantum promastigotes  was  evaluated  by  flow  cytometry  using  the  Annexin  V-FITC
(fluorescein  isothiocyanate)  Apoptosis  Kit  -  KA0714  (Abnova)  in  accordance  with  the
manufacturer's recommendations. Briefly, treated and control promastigotes were washed with
culture medium and resuspended in 500 μm film thickness; Restek, USA). These analysesL binding buffer and stained with 5 μm film thickness; Restek, USA). These analysesL of annexin V-
FITC (10 mg/mL) and 5 μm film thickness; Restek, USA). These analysesl of propidium iodide (PI; 50μm film thickness; Restek, USA). These analysesg/ml) and incubate at room temperature
for 5 min in the dark. Results were obtained by flow cytometry using a FACS Calibur Flow
Cytometer (Becton-Dickinson, East Rutherford, NJ, USA) using the Cell Quest software (BD
Biosciences, San Jose, CA, USA) for acquisition and result analysis. Ten thousand events were
analysed and apoptosis  evaluated  based on the geometric  mean of the fluorescence intensity
detected in channels 1 (for annexin) and 2 (for PI) (Farias et al., 2013).
6. Statistical analysis
The antileishmanial and cytotoxic assays were conducted in triplicate and the results were
expressed as mean and standard error of the mean (SEM). The IC50 values were calculated using
sigmoid regression on the logarithm of the concentration-response data in the GraphPad Prism V
5.0 software. Student’s t-test was used to determine whether differences between means were
significant at different levels (p < 0.05 and p < 0.01).
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Table S1. Species, date of collection and collection site of the macroalgae used in this study
Phylum /Species Date Local Country
Chlorophyta
Cladophora albida (Nees) Kutzing July 2010 Olhos de Água1 Portugal
Codium sp. Stackhouse July 2010 Olhos de Água1 Portugal
Heterokontophyta
Cladostephus spongiosus (Hudson) C. Agardh July 2010 Olhos de Água1 Portugal
Cystoseira baccata (S. G. Gmelin) P. C. Silva July 2012 Areosa2 Portugal
Cystoseira barbata (Stackhouse) C. Agardh March 2013 Cadiz Bay1 Spain
Cystoseira humilis Schousboe ex Kützing May 2012 Almograve3 Portugal
Cystoseira nodicaulis (Withering) M. Roberts April 2013 Santa Mariña2 Spain
Cystoseira tamariscifolia (Hudson) Papenfuss July 2012 Areosa2 Portugal
Cystoseira usneoides (L.) M. Roberts September 2012 Olhos de Água1 Portugal
Halopteris scoparia (L.) Sauvageau July 2010 Olhos de Água1 Portugal
Sargassum muticum (Yendo) Fensholt July 2010 Olhos de Água1 Portugal
Taonia atomaria (Woodward) J. Agardh July 2010 Olhos de Água1 Portugal
Rhodophyta
Peyssonnelia squamaria (S. G. Gmelin) Decaisne July 2013 Arrifes1 Portugal
Plocamium cartilagineum (L.) P. S. Dixon July 2012 Olhos de Água1 Portugal
Scinaia furcellata (Turner) J. Agardh July 2013 Olhos de Água1 Portugal
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aIC50 -  Inhibitory concentration of extract / compound causing 50% reduction of the promastigote and
human acute monocytic leukaemia cell  line THP-1 cells  growth;  bCC50 -  Inhibitory concentration of
extract / compound causing 50% reduction of the intracellular amastigote burden compared to the non-
treated infected controls. IC50 and CC50 values represent the mean ± standard error of the mean of three
experiments performed in triplicate.
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Table S3. Class of metabolites found in Cystoseira extracts
Species Extracts Class of metabolites1
C. baccata Hexane FA, TAG, CAR, ST
CH2Cl2 MT, FA 
MeOH MT
C.  barbata Hexane FA, TAG, CAR, ST
CH2Cl2 MT, FA
MeOH MT
C.  humilis Hexane FA, TAG, CAR
CH2Cl2 FA
MeOH FA, MT
C.  nodicaulis Hexane FA, TAG, CAR, ST
CH2Cl2 MT, FA
MeOH FA
C. tamariscifolia Hexane FA, TAG, CAR
CH2Cl2 MT, FA
MeOH MT
C.  usneoides Hexane MT, FA
CH2Cl2 MT, FA
MeOH MT
1FA - fatty acids, TAG - triacylglycerols, CAR - carotenoids, ST - steroids, MT  - meroterpenoids
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Figures
Figure S1. Effect of C. nodicaulis and C. barbata hexane extracts (125 µg/mL, 48h) on the 
morphology of L. infantum promastigotes. Control cells cultured in RPMI medium alone (A) 
treated with the control drug amphotericin B (0.2 µg/mL; B), and treated with C. nodicaulis (C) 








Figure S2. 1H NMR spectra (500 MHz, CDCl3) of the Cystoseira baccata (A), C. barbata (B) C.




Figure S3. 1H NMR spectra (500 MHz, CDCl3) of the Cystoseira. baccata (A), C. barbata (B), 
C. tamariscifolia (C) and C. usneoides (D) CH2Cl2 extracts.
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